We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 606

U.S. Trade Rep launches WTO action against India
  • Shook Hardy & Bacon LLP
  • India, USA
  • February 13 2014

U.S. Trade Representative Michael Froman has announced that the United States has requested dispute settlement consultations with India before the


FDA issues final guidance on mobile medical apps
  • Shook Hardy & Bacon LLP
  • USA
  • September 26 2013

With an oversight focus on those who develop mobile medical applications (apps) that are intended to be used as an accessory to a regulated medical


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • November 13 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry and staff titled "Molecular Diagnostic Instruments with Combined


New medical device regulations issued in Malaysia, effective July 1
  • Shook Hardy & Bacon LLP
  • Malaysia
  • February 8 2013

Malaysia's Minister of Health has approved medical device regulations under the Medical Device Act 2012 (Act 737); they were published in the Federal


Pharma trade group seeks biologics data exclusivity for international trade
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2011

PhRMA has reportedly called for the U.S. Trade Representative to go outside provisions in the Korea-U.S. trade deal (KORUS) and press for a 12-year period of exclusivity for biologics in ongoing Trans-Pacific Partnerships (TPP) negotiations


Medicinova and Zhejiang Medicine announce joint venture in China
  • Shook Hardy & Bacon LLP
  • China, USA
  • March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China


Barbados launches biotech initiative designed to shorten R&D process
  • Shook Hardy & Bacon LLP
  • Barbados
  • December 16 2010

The Barbados government has recently launched two initiatives to attract biotech companies to the island nation


Takeda acquires access to Envoy’s CNS drug pipeline and bacTRAP technology
  • Shook Hardy & Bacon LLP
  • USA
  • November 15 2012

Takeda America Holdings, Inc. has reportedly acquired Envoy Therapeutics, Inc. in a deal worth $140 million, including an up-front payment and progressdependent milestone payments


Cuba, China agree to strengthen biotechnology collaboration
  • Shook Hardy & Bacon LLP
  • China, Cuba
  • December 15 2011

Cuba and China have reportedly signed agreements to deepen their collaboration on biotechnology


Presidential bioethics panel to examine genome privacy
  • Shook Hardy & Bacon LLP
  • USA
  • April 19 2012

The Presidential Commission for the Study of Bioethical Issues is seeking public comments “on the ethical issues raised by the ready availability of large-scale human genome sequence data, with regard to privacy and data access and the balancing of individual and societal interests.”